Clinical Trial Update: Avandamet Bioequivalence Study Brazil - Fed Administration [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of Avandamet in Brazil completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandamet (rosiglitazone/metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2011-04-08